INS and Insulin resistance: Major treatments include Statins, which reduce hepatic cholesterol synthesis and the amount of Low-Density Lipoprotein (LDL) levels in the body, and Metformin, the most widely used insulin-sensitizing agent, which improves insulin resistance by inhibiting hepatic glucose production and enhancing glucose uptake in adipose tissue and skeletal muscle [58].